Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Research breakthroughs prompt ‘renaissance’ of collaboration between oncologists, HIV experts
• An AIDS-free generation: Fantasy or reality? Mark W. Kline, MD
• Rabies death reported in detention facility
• Online restaurant reviews identified three foodborne illness outbreaks
• Possible clinical predictors of MERS identified
• CDC: Measles in the US at 20-year high
• CDC: Awareness needed for neglected parasitic infections in US
• CDC: No person-to-person spread of MERS among Midwest cases
• Dengue warning system developed for World Cup in Brazil
• New guidelines recommend PrEP for those at substantial risk
• USPSTF: Screen high-risk individuals for HBV
• WHO: Wild poliovirus transmission international concern
• IDSA, HIVMA voice support for syringe exchange programs
• Initiative launched in Congress to bolster new antibiotic development
• Collaboration formed to increase adult immunization rates
• New guidelines focus on prevention of C. difficile in health care settings
• Why ID specialists should take a stand against African anti-gay legislation Joel Gallant, MD, MPH
• Epidemic in West Africa: The mystery infection known as Ebola virus disease Donald Kaye, MD, MACP
• Ciprofloxacin inhalant powder given orphan drug status
• NRTI, NNRTI mutations common in resource-limited settings
• Updated guidelines aim to prevent surgical site infections, reduce costs
• Bisexual male teens exhibit riskiest sexual behavior
• Infectious disease mortality rates higher among American Indians, Alaska Natives
• Asymptomatic bacteriuria increased risk for prosthetic joint infection
• Ceftobiprole noninferior to combination treatment for HAP
• Despite early ART, mortality high in adults with HIV, TB
• IDUs showed willingness to receive education, treatment for HCV
• Intrapartum antibiotic lowered early-onset neonatal GBS sepsis rate
• Malaria outbreak among Guatemalan peacekeepers traced to Congo
• Sepsis accounts for large percentage of hospital deaths
• Small incentives improved linkage to HIV care among drug users
• STIs more common among at-risk adolescent females
• Tdap during pregnancy did not increase adverse events for mother or child
• Unique, divergent avian influenza virus found in Antarctic penguins
• E. coli load higher in urban vs. hospital wastewater
• No difference in severity, outcomes between influenza A and B
• Janssen submits NDA for simeprevir/sofosbuvir combination HCV regimen
• Sanofi Pasteur releases dengue vaccine results
• AbbVie files to market all-oral, interferon-free HCV treatment in Europe
• Incidence of CDIs in Europe increased since 2008
• Only half of postpartum women with HBV undergo follow-up testing
• Perceived risks still influence pregnant women’s intent to vaccinate
• No concerning safety patterns for HPV4 during pregnancy
• Drug resistance linked to outbreak of E. meningoseptica in ICU
• HPV detected in more than two-thirds of US adults
• Levofloxacin linked to increased incidence of viridans streptococci
• Bacteria linger up to a week inside airplanes
• DAA regimen yielded high SVR rates without ribavirin
• Difficult-to-treat HCV patients benefit from ledipasvir, sofosbuvir combo
• DNA influenza vaccine safe, immunogenic in children
• Elderly at high risk for CDI hospital readmission
• Exposure to e-cigarette vapor increases MRSA virulence
• HCV genotype 4 patients achieved SVR12 with triple therapy
• Improved detection methods needed to prevent neonatal HSV
• Initial HSV viral load did not predict clinical outcomes, neuroradiological disease
• LAIV effective in children despite prior vaccination
• Many parents who intend to vaccinate their adolescents against HPV do not do so
• Preventability of some hospital-acquired conditions questioned
• Prophylactic antibiotics prevented UTI recurrences in children with VUR
• Quadruple concomitant therapy better than triple therapy for H. pylori
• Rates of gonorrhea at all-time low among adolescents
• Readmissions common in young children hospitalized with pneumonia
• Re-treatment with sofosbuvir, interferon effective in HCV genotype 2 or 3
• SAPPHIRE-II: Interferon-free treatment combo a success for genotype 1 HCV
• Serious challenges remain in dengue vaccine development
• Sofosbuvir regimen outperformed other therapies in reducing liver complications in HCV patients
• Two-drug, 12-week treatment successful for genotype 1 HCV
• Windshield washer fluid possible exposure route for Legionnaires' disease
• HCV treatment strategies on the horizon Kimberly Boeser, PharmD, MPH, BCIDP
• Middle East respiratory syndrome coronavirus: Zoonotic aspects Arnon Shimshony, DVM